Loading company…
Tampere-based Magnasense develops saliva-based diagnostic tests for oral health, drug monitoring and infectious diseases.
Founded in 2009 and headquartered in Tampere, Finland, Magnasense produces saliva-based diagnostic tests for oral health, therapeutic drug monitoring and infectious diseases, designed for use by professionals or at home. Its products are marketed mainly in Europe, North America and select Asian markets to healthcare providers, pharmacies and consumers. The company raised a total of USD 0.19 mn, with its latest round on June 1, 2009, backed by investors including Midinvest Management and Tesi. It is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in